• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by CareDx Inc.

    11/14/24 5:13:57 PM ET
    $CDNA
    Medical Specialities
    Health Care
    Get the next $CDNA alert in real time by email
    SC 13G/A 1 d854179dsc13ga.htm SC 13G/A SC 13G/A

     

     

    United States

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     

     

    CareDX, Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    14167L103

    (CUSIP Number)

    September 30, 2024

    (Date of Event Which Requires Filing This Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 14167L103

     

     1.   

     Names of Reporting Persons

     

     Bellevue Asset Management (UK) Ltd.

     2.  

     Check the Appropriate Box if a Member of a Group (See Instructions)

     (a) ☒  (b) ☐

     

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     England and Wales

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    with:

       5.    

     Sole Voting Power

     

     0

       6.   

     Shared Voting Power

     

     3,128,913

       7.   

     Sole Dispositive Power

     

     0

       8.   

     Shared Dispositive Power

     

     3,128,913

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     3,128,913

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     ☐

    11.  

     Percent of Class Represented by amount in Row (9)

     

     5.8%

    12.  

     Type of Reporting Person (See Instructions)

     

     FI


    CUSIP No. 14167L103

     

     1.   

     Names of Reporting Persons

     

     Bellevue Group AG

     2.  

     Check the Appropriate Box if a Member of a Group (See Instructions)

     (a) ☒  (b) ☐

     

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Switzerland

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    with:

       5.    

     Sole Voting Power

     

     0

       6.   

     Shared Voting Power

     

     3,145,546

       7.   

     Sole Dispositive Power

     

     0

       8.   

     Shared Dispositive Power

     

     3,145,546

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     3,145,546

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     ☐

    11.  

     Percent of Class Represented by amount in Row (9)

     

     5.9%

    12.  

     Type of Reporting Person (See Instructions)

     

     CO, HC


    CUSIP No. 14167L103

     

     1.   

     Names of Reporting Persons

     

     Bellevue Asset Management AG

     2.  

     Check the Appropriate Box if a Member of a Group (See Instructions)

     (a) ☒  (b) ☐

     

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Switzerland

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    with:

       5.    

     Sole Voting Power

     

     0

       6.   

     Shared Voting Power

     

     16,543

       7.   

     Sole Dispositive Power

     

     0

       8.   

     Shared Dispositive Power

     

     16,543

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     16,543

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     ☐

    11.  

     Percent of Class Represented by amount in Row (9)

     

     0.0%

    12.  

     Type of Reporting Person (See Instructions)

     

     CO, HC, FI


    Item 1

    1(a) Name of Issuer: CareDX, Inc.

    1(b) Address of Issuer’s Principal Executive Offices:

    3260 Bayshore Boulevard, Brisbane, CA 94005

    Item 2

    2(a) Name of Person Filing: Bellevue Group AG (“Bellevue Group”) on behalf of its wholly-owned subsidiaries, Bellevue Asset Management (UK) Ltd. (“BAM UK”) and Bellevue Asset Management AG (“BAM,” and together with Bellevue Group and BAM UK, the “Reporting Persons”).

    2(b) Address of Principal Business Office or, if none, Residence:

    Bellevue Group: Seestrasse 16, Kuesnacht, Switzerland, CH-8700

    BAM:     Seestrasse 16, Kuesnacht, Switzerland, CH-8700

    BAM UK:  32 London Bridge Street, 24th Floor, London, England SE1 9SG

    2(c) Citizenship:

    Bellevue Group: Switzerland

    BAM: Switzerland

    BAM UK: England and Wales

    2(d) Title of Class of Securities: Common Stock

    2(e) CUSIP Number: 14167L103

    Item 4. Ownership

    The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

    This statement is filed jointly by Bellevue Group, BAM and BAM UK. BAM UK is a wholly-owned subsidiary of BAM. Each of BAM UK and BAM is a wholly-owned subsidiary of Bellevue Group.


    Item 10. Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    By signing below I also certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to investment advisers and investment companies is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.


    SIGNATURES

    After reasonable inquiry and the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Bellevue Asset Management (UK) Ltd.      
    Date: November 14, 2024     By:  

    /s/ Markus Peter

          Signatory Authority
        Name:   Markus Peter
        Title:   Director
    Bellevue Group AG      
    Date: November 14, 2024     By:  

    /s/ Stefano Montalbano

          Signatory Authority
        Name:   Stefano Montalbano
        Title:   Chief Financial Officer
    Date: November 14, 2024     By:  

    /s/ Christoph Eisenring

          Signatory Authority
        Name:   Christoph Eisenring
        Title:   Head Legal & Compliance
    Bellevue Asset Management AG      
    Date: November 14, 2024     By:  

    /s/ Martin Gubler

          Signatory Authority
        Name:   Martin Gubler
        Title:   Chief Financial Officer
    Date: November 14, 2024     By:  

    /s/ Ivo Betschart

          Signatory Authority
        Name:   Ivo Betschart
        Title:   Chief Finance & Controlling
    Get the next $CDNA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDNA

    DatePrice TargetRatingAnalyst
    1/15/2025$28.00 → $24.00Underweight → Equal Weight
    Wells Fargo
    8/28/2024$28.00Underweight
    Wells Fargo
    8/19/2024$40.00Neutral → Buy
    BTIG Research
    5/13/2024Outperform → Mkt Perform
    Raymond James
    5/1/2024$15.00Hold → Buy
    Craig Hallum
    11/9/2023$10.00Equal-Weight → Overweight
    Stephens
    8/15/2023$12.00Mkt Perform → Outperform
    Raymond James
    5/11/2023Buy → Neutral
    BTIG Research
    More analyst ratings

    $CDNA
    SEC Filings

    See more
    • CareDx Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - CareDx, Inc. (0001217234) (Filer)

      6/12/25 4:32:37 PM ET
      $CDNA
      Medical Specialities
      Health Care
    • SEC Form 144 filed by CareDx Inc.

      144 - CareDx, Inc. (0001217234) (Subject)

      6/11/25 4:20:36 PM ET
      $CDNA
      Medical Specialities
      Health Care
    • CareDx Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - CareDx, Inc. (0001217234) (Filer)

      6/3/25 4:30:13 PM ET
      $CDNA
      Medical Specialities
      Health Care